Game-changing cholesterol pill wins FDA approval after cutting LDL nearly 60%
Top Story
Archived
•
July 16, 2026
•
2 views
Lipfendra, the first once-daily oral PCSK9 inhibitor, was shown to reduce LDL cholesterol by roughly 56% to 60% when combined with statins.
Source: https://moxie.foxnews.com/google-publisher/latest.xml - Read Original
"We build AI or anything ICST"
"Because adventure is exploring the unknown"
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"What you put in is not always what you get out."
"Commision Art Work or Just pure Beauty."